Extensive liver resection with preoperative regional chemotherapy for colorectal metastases in patients with high risk of blood loss
- Authors: Lazarev A.F1, Mamontov K.G1, Kotelnikov A.G2, Lubennikov V.A1, Khays S.L1
-
Affiliations:
- Altai branch of N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences
- N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences
- Issue: Vol 19, No 1 (2014)
- Pages: 4-7
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40017
- DOI: https://doi.org/10.17816/onco40017
- ID: 40017
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A. F Lazarev
Altai branch of N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences656049, Barnaul, Russian Federation
K. G Mamontov
Altai branch of N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences
Email: mamontovkg@mail.ru
канд. мед. наук, зав. отд-нием рентгенохирургических методов диагностики и лечения злокачественных опухолей 656049, Barnaul, Russian Federation
A. G Kotelnikov
N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences115478, Moscow, Russian Federation
V. A Lubennikov
Altai branch of N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences656049, Barnaul, Russian Federation
S. L Khays
Altai branch of N.N. Blokhin Russian Cancer Research Center under the Russian Academy of Medical Sciences656049, Barnaul, Russian Federation
References
- Журавлев В.А. Радикальные операции у «неоперабельных» больных с очаговыми поражениями печени. Киров: Вятка; 2000.
- Патютко Ю.И. Хирургическое лечение злокачественных опухолей печени. М.: Медицина; 2005.
- Патютко Ю.И., Пылев А.Л., Сагайдак И.В., Котельников А.Г. и др. Современные подходы к лечению метастазов колоректального рака в печению. Вестник хирургической гастроэнтерологии. 2008; 4: 14-28.
- Вишневский В.А., Назаренко Н.А., Икрамов Р.З., Рузавин B.C., Козырин И.А. Обширные резекции печени при высоком риске массивной кровопотери. Альманах Института хирургии имени А.В. Вишневского. 2008; 3(3): 18-22.
- Adam R., Laurel A., Azoulay D. et al. Twostagehepatectomy: A planned strategy to treat irresectable liver tumors. Ann. Surg. 2000; 232: 777-85.
- Adam R., Pascal G., Castaing D. et al. Tumor progression while on chemotherapy. A contraindication to liver resection for multiple colorectal metastases? Ann. Surg. 2004; 240: 1052-64.
- Azoulay D., Andreani P., Maggi U. et al. Combined liver resection and reconstruction of the supra-renal vena cava: The Paul Brousse experience. Ann. Surg. 2006; 244: 80-8.
- Кетеnу M.M., Adak S., Gray B. et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J. Clin. Oncol. 2002; 20(6):1499-505.
- Abdalla E.K., Adam R. et al. Improving respectability of hepatic colorectal metastases: Expert consensus statement. Ann. Surg. Oncol. 2006; 13(10): 1271-80.
- Clavien P.-A., Petrowsky H. et al. Strategius for safer liver surgeri and partial liver transplantation. N. Engl. J. Med. 2007; 356(15): 1545-59.
- Tournigand C., Andre T., Achille E. et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR Study. J. Clin. Oncol. 2004; 22: 229-37.
- Nordlinger B., Sorbye H., Debois M. et al. Feasibility and risks of preoperative chemotherapy with FOLFOX 4 and surgery for resectable colorectal liver metastases: Interim results of the EORTC Intergroup randomized phase III study. J. Clin. Oncol. 2005; 23 (Suppl.): 253.
- Saltz L.B., Cox J.V., Blanke C. et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N. Engl. J. Med. 2000; 343(13): 905-14.
- Gruenberger T., Tamandl D., Puhalla H. et al. Bevacizumab plus XELOX as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. In: Meeting Proceedings 43rd ASCO. 2007: Abstr. 4064.
- D’Angelica M., Komprat P., Gonen M. et al. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann. Surg. Oncol. 2007; 14(2): 759-65.